Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.

Siles AM, Martínez-Hernández E, Araque J, Diaz-Manera J, Rojas-Garcia R, Gallardo E, Illa I, Graus F, Querol L.

Ann Clin Transl Neurol. 2018 Mar 26;5(5):559-569. doi: 10.1002/acn3.554. eCollection 2018 May.

2.

Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.

Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 May 29;90(22):e1964-e1972. doi: 10.1212/WNL.0000000000005614. Epub 2018 Apr 27.

PMID:
29703767
3.

Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.

Hara M, Martinez-Hernandez E, Ariño H, Armangué T, Spatola M, Petit-Pedrol M, Saiz A, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 Apr 17;90(16):e1386-e1394. doi: 10.1212/WNL.0000000000005329. Epub 2018 Mar 16.

PMID:
29549218
4.

Regulation of the voltage-gated Ca2+ channel CaVα2δ-1 subunit expression by the transcription factor Egr-1.

González-Ramírez R, Martínez-Hernández E, Sandoval A, Gómez-Mora K, Felix R.

Neurosci Lett. 2018 Apr 23;673:136-141. doi: 10.1016/j.neulet.2018.03.005. Epub 2018 Mar 5.

PMID:
29518540
5.

[Progressive encephalitis due to anti-DPPX antibodies: a case with good response to treatment with rituximab].

Valero-Lopez G, Martin-Fernandez JJ, Hernandez-Clares R, Baidez-Guerrero AE, Martinez-Hernandez E.

Rev Neurol. 2017 Dec 1;65(11):525-526. Spanish.

6.

Antibody-associated CNS syndromes without signs of inflammation in the elderly.

Escudero D, Guasp M, Ariño H, Gaig C, Martínez-Hernández E, Dalmau J, Graus F.

Neurology. 2017 Oct 3;89(14):1471-1475. doi: 10.1212/WNL.0000000000004541. Epub 2017 Sep 6.

PMID:
28878050
7.

Postmalaria neurologic syndrome associated with neurexin-3α antibodies.

Costa A, Silva-Pinto A, Alves J, Neves N, Martínez-Hernández E, Abreu P, Sarmento A.

Neurol Neuroimmunol Neuroinflamm. 2017 Aug 21;4(5):e392. doi: 10.1212/NXI.0000000000000392. eCollection 2017 Sep. No abstract available.

8.

Insight-Based Approach for the Design of Integrated Local Food-Energy-Water Systems.

Leung Pah Hang MY, Martinez-Hernandez E, Leach M, Yang A.

Environ Sci Technol. 2017 Aug 1;51(15):8643-8653. doi: 10.1021/acs.est.7b00867. Epub 2017 Jul 17.

PMID:
28686428
9.

Organic waste as a sustainable feedstock for platform chemicals.

Coma M, Martinez-Hernandez E, Abeln F, Raikova S, Donnelly J, Arnot TC, Allen MJ, Hong DD, Chuck CJ.

Faraday Discuss. 2017 Sep 21;202:175-195. doi: 10.1039/c7fd00070g.

10.

Material flow and sustainability analyses of biorefining of municipal solid waste.

Sadhukhan J, Martinez-Hernandez E.

Bioresour Technol. 2017 Nov;243:135-146. doi: 10.1016/j.biortech.2017.06.078. Epub 2017 Jun 17.

PMID:
28651133
11.

Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma.

Sepúlveda M, Martinez-Hernandez E, Gaba L, Victoria I, Sola-Valls N, Falgàs N, Casanova-Molla J, Graus F.

Muscle Nerve. 2017 Dec;56(6):E162-E167. doi: 10.1002/mus.25672. Epub 2017 May 16.

PMID:
28439919
12.

DPPX antibody-associated encephalitis: Main syndrome and antibody effects.

Hara M, Ariño H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, Schreurs MW, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2017 Apr 4;88(14):1340-1348. doi: 10.1212/WNL.0000000000003796. Epub 2017 Mar 3.

13.

Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).

Guasp M, Solà-Valls N, Martínez-Hernández E, Gil MP, González C, Brieva L, Saiz A, Dalmau J, Graus F, Ariño H.

J Neuroimmunol. 2016 Nov 15;300:15-17. doi: 10.1016/j.jneuroim.2016.09.019. Epub 2016 Oct 5.

14.

Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

Ariño H, Armangué T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, Lancaster E, Saiz A, Dalmau J, Graus F.

Neurology. 2016 Aug 23;87(8):759-65. doi: 10.1212/WNL.0000000000003009. Epub 2016 Jul 27.

15.

Human neurexin-3α antibodies associate with encephalitis and alter synapse development.

Gresa-Arribas N, Planagumà J, Petit-Pedrol M, Kawachi I, Katada S, Glaser CA, Simabukuro MM, Armangué T, Martínez-Hernández E, Graus F, Dalmau J.

Neurology. 2016 Jun 14;86(24):2235-42. doi: 10.1212/WNL.0000000000002775. Epub 2016 May 11.

16.

Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.

Sepúlveda M, Armangue T, Martinez-Hernandez E, Arrambide G, Sola-Valls N, Sabater L, Téllez N, Midaglia L, Ariño H, Peschl P, Reindl M, Rovira A, Montalban X, Blanco Y, Dalmau J, Graus F, Saiz A.

J Neurol. 2016 Jul;263(7):1349-60. doi: 10.1007/s00415-016-8147-7. Epub 2016 May 4.

17.

Novel integrated mechanical biological chemical treatment (MBCT) systems for the production of levulinic acid from fraction of municipal solid waste: A comprehensive techno-economic analysis.

Sadhukhan J, Ng KS, Martinez-Hernandez E.

Bioresour Technol. 2016 Sep;215:131-143. doi: 10.1016/j.biortech.2016.04.030. Epub 2016 Apr 9.

PMID:
27085988
18.

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

Martinez-Hernandez E, Ariño H, McKeon A, Iizuka T, Titulaer MJ, Simabukuro MM, Lancaster E, Petit-Pedrol M, Planagumà J, Blanco Y, Harvey RJ, Saiz A, Graus F, Dalmau J.

JAMA Neurol. 2016 Jun 1;73(6):714-20. doi: 10.1001/jamaneurol.2016.0133.

19.

Orthostatic myoclonus associated with Caspr2 antibodies.

Gövert F, Witt K, Erro R, Hellriegel H, Paschen S, Martinez-Hernandez E, Wandinger KP, Deuschl G, Dalmau J, Leypoldt F.

Neurology. 2016 Apr 5;86(14):1353-5. doi: 10.1212/WNL.0000000000002547. Epub 2016 Mar 4. No abstract available.

20.

Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Armangué T, Sabater L, Torres-Vega E, Martínez-Hernández E, Ariño H, Petit-Pedrol M, Planagumà J, Bataller L, Dalmau J, Graus F.

JAMA Neurol. 2016 Apr;73(4):417-24. doi: 10.1001/jamaneurol.2015.4607.

21.

Spondylotic myelopathy mimicking myelitis: diagnostic clues by magnetic resonance imaging.

Rua A, Blanco Y, Sepúlveda M, Sola-Valls N, Martínez-Hernández E, Llufriu S, Berenguer J, Graus F, Saiz A.

Rev Neurol. 2015 Dec 1;61(11):499-502. English, Spanish.

22.

Telemedicine for Monitoring MS Activity and Progression.

Sola-Valls N, Blanco Y, Sepúlveda M, Martinez-Hernandez E, Saiz A.

Curr Treat Options Neurol. 2015 Nov;17(11):47. doi: 10.1007/s11940-015-0377-y.

PMID:
26423914
23.

Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.

Ariño H, Höftberger R, Gresa-Arribas N, Martínez-Hernández E, Armangue T, Kruer MC, Arpa J, Domingo J, Rojc B, Bataller L, Saiz A, Dalmau J, Graus F.

JAMA Neurol. 2015 Aug;72(8):874-81. doi: 10.1001/jamaneurol.2015.0749.

24.

Impact of bioenergy production on ecosystem dynamics and services-a case study on U.K. Heathlands.

Martinez-Hernandez E, Leach M, Yang A.

Environ Sci Technol. 2015 May 5;49(9):5805-12. doi: 10.1021/es505702j. Epub 2015 Apr 16.

PMID:
25855030
25.

Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.

Gresa-Arribas N, Ariño H, Martínez-Hernández E, Petit-Pedrol M, Sabater L, Saiz A, Dalmau J, Graus F.

PLoS One. 2015 Mar 16;10(3):e0121364. doi: 10.1371/journal.pone.0121364. eCollection 2015.

26.

Calcium current homeostasis and synaptic deficits in hippocampal neurons from Kelch-like 1 knockout mice.

Perissinotti PP, Ethington EA, Almazan E, Martínez-Hernández E, Kalil J, Koob MD, Piedras-Rentería ES.

Front Cell Neurosci. 2015 Jan 7;8:444. doi: 10.3389/fncel.2014.00444. eCollection 2014.

27.

Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis.

Martinez-Hernandez E, Sepulveda M, Rostásy K, Höftberger R, Graus F, Harvey RJ, Saiz A, Dalmau J.

JAMA Neurol. 2015 Feb;72(2):187-93. doi: 10.1001/jamaneurol.2014.3602.

28.

Cortactin autoantibodies in myasthenia gravis.

Gallardo E, Martínez-Hernández E, Titulaer MJ, Huijbers MG, Martínez MA, Ramos A, Querol L, Díaz-Manera J, Rojas-García R, Hayworth CR, Verschuuren JJ, Balice-Gordon R, Dalmau J, Illa I.

Autoimmun Rev. 2014 Oct;13(10):1003-7. doi: 10.1016/j.autrev.2014.08.039. Epub 2014 Sep 3.

PMID:
25193850
29.

Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

Ariño H, Gresa-Arribas N, Blanco Y, Martínez-Hernández E, Sabater L, Petit-Pedrol M, Rouco I, Bataller L, Dalmau JO, Saiz A, Graus F.

JAMA Neurol. 2014 Aug;71(8):1009-16. doi: 10.1001/jamaneurol.2014.1011.

30.

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.

Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, McCracken L, Martinez-Hernandez E, Mason WP, Kruer MC, Ritacco DG, Grisold W, Meaney BF, Alcalá C, Sillevis-Smitt P, Titulaer MJ, Balice-Gordon R, Graus F, Dalmau J.

Lancet Neurol. 2014 Mar;13(3):276-86. doi: 10.1016/S1474-4422(13)70299-0. Epub 2014 Jan 22.

31.

Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.

González-Ramírez R, Martínez-Hernández E, Sandoval A, Felix R.

J Cell Physiol. 2014 May;229(5):551-60. doi: 10.1002/jcp.24432.

PMID:
23868804
32.

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J.

Lancet Neurol. 2013 Feb;12(2):157-65. doi: 10.1016/S1474-4422(12)70310-1. Epub 2013 Jan 3.

33.

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.

Querol L, Nogales-Gadea G, Rojas-Garcia R, Martinez-Hernandez E, Diaz-Manera J, Suárez-Calvet X, Navas M, Araque J, Gallardo E, Illa I.

Ann Neurol. 2013 Mar;73(3):370-80. doi: 10.1002/ana.23794. Epub 2012 Dec 31.

PMID:
23280477
34.

Isolation and characterization of the 5´-upstream region of the human voltage-gated Ca(2+) channel α 2δ-1 auxiliary subunit gene: promoter analysis and regulation by transcription factor Sp1.

Martínez-Hernández E, González-Ramírez R, Sandoval A, Cisneros B, Delgado-Lezama R, Felix R.

Pflugers Arch. 2013 Jun;465(6):819-28. doi: 10.1007/s00424-012-1194-8. Epub 2012 Dec 15.

PMID:
23242029
35.

Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J.

Ann Neurol. 2013 Jan;73(1):120-8. doi: 10.1002/ana.23756. Epub 2012 Dec 7.

36.

Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype.

McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J.

JAMA Neurol. 2013 Jan;70(1):44-50. doi: 10.1001/jamaneurol.2013.574.

37.

Long-lasting treatment effect of rituximab in MuSK myasthenia.

Díaz-Manera J, Martínez-Hernández E, Querol L, Klooster R, Rojas-García R, Suárez-Calvet X, Muñoz-Blanco JL, Mazia C, Straasheijm KR, Gallardo E, Juárez C, Verschuuren JJ, Illa I.

Neurology. 2012 Jan 17;78(3):189-93. doi: 10.1212/WNL.0b013e3182407982. Epub 2012 Jan 4.

PMID:
22218276
38.

Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.

Lancaster E, Martinez-Hernandez E, Titulaer MJ, Boulos M, Weaver S, Antoine JC, Liebers E, Kornblum C, Bien CG, Honnorat J, Wong S, Xu J, Contractor A, Balice-Gordon R, Dalmau J.

Neurology. 2011 Nov 1;77(18):1698-701. doi: 10.1212/WNL.0b013e3182364a44. Epub 2011 Oct 19.

39.

Paraneoplastic upbeat nystagmus.

Wray SH, Martinez-Hernandez E, Dalmau J, Maheshwari A, Chen A, King S, Bishop Pitman M, Leigh RJ.

Neurology. 2011 Aug 16;77(7):691-3. doi: 10.1212/WNL.0b013e318229e6a5. Epub 2011 Aug 3. No abstract available.

40.

Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis.

Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J.

Neurology. 2011 Aug 9;77(6):589-93. doi: 10.1212/WNL.0b013e318228c136. Epub 2011 Jul 27.

41.

Encephalitis and antibodies to synaptic and neuronal cell surface proteins.

Lancaster E, Martinez-Hernandez E, Dalmau J.

Neurology. 2011 Jul 12;77(2):179-89. doi: 10.1212/WNL.0b013e318224afde. Review.

42.

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.

Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, Wilson C, Jacobs D, Lai M, Walker RW, Graus F, Bataller L, Illa I, Markx S, Strauss KA, Peles E, Scherer SS, Dalmau J.

Ann Neurol. 2011 Feb;69(2):303-11. doi: 10.1002/ana.22297.

43.

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R.

Lancet Neurol. 2011 Jan;10(1):63-74. doi: 10.1016/S1474-4422(10)70253-2. Review.

44.

Inhibition of recombinant N-type and native high voltage-gated neuronal Ca2+ channels by AdGABA: mechanism of action studies.

Martínez-Hernández E, Sandoval A, González-Ramírez R, Zoidis G, Felix R.

Toxicol Appl Pharmacol. 2011 Feb 1;250(3):270-7. doi: 10.1016/j.taap.2010.10.030. Epub 2010 Nov 6.

PMID:
21059371
45.

Remote cerebral hematomas in patients treated with intravenous rt-PA.

Martínez-Hernández E, Martínez-Ramírez S, Delgado-Mederos R, Alcolea D, Marquié M, Marín R, De Juan M, Martí-Vilalta JL, Martí-Fàbregas J.

J Neurol. 2010 Jul;257(7):1062-6. doi: 10.1007/s00415-010-5462-2. Epub 2010 Feb 6.

PMID:
20140445
46.

Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(alpha2-3)Gal.

Rojas-Garcia R, Gallardo E, De Luna N, Juarez C, Martinez-Hernandez E, Carvajal A, Casasnovas C, Fages E, Davila-González P, Illa I.

J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):623-8. doi: 10.1136/jnnp.2009.183517. Epub 2009 Sep 2.

PMID:
19726412
47.

Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study.

Tessa A, Fiermonte G, Dionisi-Vici C, Paradies E, Baumgartner MR, Chien YH, Loguercio C, de Baulny HO, Nassogne MC, Schiff M, Deodato F, Parenti G, Rutledge SL, Vilaseca MA, Melone MA, Scarano G, Aldamiz-Echevarría L, Besley G, Walter J, Martinez-Hernandez E, Hernandez JM, Pierri CL, Palmieri F, Santorelli FM.

Hum Mutat. 2009 May;30(5):741-8. doi: 10.1002/humu.20930.

PMID:
19242930
48.

[Neurological complications of transplantation].

Martínez-Hernández E, Rosenfeld MR, Pruitt A, Dalmau J.

Neurologia. 2008 Jul-Aug;23(6):373-86. Review. Spanish.

PMID:
18597192
49.

[Diagnosis of chronic leptospirosis, comparison between the microscopic agglutination and three confirmatory diagnostic techniques].

Velasco-Castrejón O, Rivas Sánchez B, Espinoza Hernández J, Martínez Hernández E.

Rev Cubana Med Trop. 2007 Jan-Apr;59(1):8-13. Spanish.

PMID:
23427411
50.

[Working with the scientific method].

García Vallejo R, Martínez Hernández E, Amal Selfa R, Cañada DA.

Rev Enferm. 2004 Jan;27(1):15-8. Spanish.

PMID:
15040591

Supplemental Content

Loading ...
Support Center